ITPR3-associated Immunodeficiency 133 with Ectodermal Dysplasia: A Caregiver Guide
At a Glance
ITPR3-associated immunodeficiency 133 is a very rare genetic condition that can weaken immune cells called T cells and affect sweating, hair, teeth, skin, and peripheral nerves. Care includes infection monitoring, heat safety, and specialist decisions about a stem cell transplant.
ITPR3-associated Immunodeficiency 133 with Ectodermal Dysplasia is an ultra-rare genetic condition that affects the body’s internal “messaging system.” At the center of this condition is a pathogenic variant in the ITPR3 gene, which normally helps cells manage calcium. Because calcium is a vital signal for many different systems, a disruption in this gene acts like a glitch in a building’s electrical wiring, impacting the immune system, the skin and teeth, and the nerves [1][2].
Because this diagnosis is based on a very small number of published cases, the medical community is still learning about its full spectrum, and not every child will have all features. A primary aspect of this diagnosis is often its impact on the immune system, known as combined immunodeficiency. The body struggles to produce and activate T-cells, the specialized white blood cells that act as both “scouts” and “soldiers” to fight off germs. Without a fully functioning T-cell population, children are more susceptible to severe or unusual infections. Research has specifically noted a risk for a severe immune overreaction called HLH, which can be triggered by common viruses like EBV [3][4].
Beyond the immune system, the condition may also affect “ectodermal” tissues, which include the hair, teeth, skin, and sweat glands. This can result in thin hair, missing or oddly shaped teeth, and a reduced ability to sweat (anhidrosis), making it difficult for the body to cool itself down in the heat. Additionally, some children develop peripheral neuropathy, a type of nerve weakness that can cause difficulty with balance or walking, similar to Charcot-Marie-Tooth disease. Not every child will show symptoms in all three of these areas, as the condition is highly variable [3][1][5].
Managing this condition requires a dedicated team of specialists, including immunologists, neurologists, and dermatologists, who work together to monitor your child’s health. While daily care focuses on preventing infections and managing symptoms like heat intolerance, doctors may also discuss long-term options such as evaluating for a hematopoietic stem cell transplant (HSCT). Although a transplant evaluation may be discussed to address the immune deficiency, HSCT carries major risks, does not guarantee normal immune function, and does not correct the skin or nerve issues, meaning a multidisciplinary approach remains essential for long-term well-being [4][6].
Receiving such a rare diagnosis is a significant life event, but modern genetic and immunological research is rapidly advancing our understanding of how to protect and support children with ITPR3-associated conditions. You are now part of a specialized medical community focused on navigating this journey with precision and care [7][8].
In this guide
6 chapters
Understanding Your Child's ITPR3 Diagnosis
Learn what ITPR3-associated immunodeficiency may mean for your child, including immune, skin, nerve, and growth features, monitoring, and treatment options.
Recognizing Symptoms and Emergency Red Flags
Learn the warning signs of ITPR3-associated immunodeficiency, including infections, ectodermal changes, neuropathy, fever, HLH, and breathing emergencies.
The Biology and Science of ITPR3 Pathogenic Variants
Learn how ITPR3 variants cause Immunodeficiency 133, affect calcium signaling, and guide genetic and immune testing, including T-cell counts and flow cytometry.
Standard Interventions and Transplant Considerations
Learn how ITPR3 immunodeficiency 133 is managed with infection prevention, immunoglobulin therapy, EBV monitoring, and stem-cell transplant evaluation.
Day-to-Day Life and Ongoing Care
Learn care strategies for Immunodeficiency 133, including heat safety, peripheral neuropathy, dental and skin care, infection prevention, and school support.
Building Your Care Team and Preparing for Visits
Learn how to build a care team for ITPR3-associated Immunodeficiency 133 and prepare genetic, immune, infection, skin, dental, and neurology records for visits.
Common questions in this guide
What health problems can this ITPR3-related condition cause in children?
Why might my child need EBV monitoring?
When might a stem cell transplant evaluation be discussed?
How can I recognize heat problems from reduced sweating?
What might peripheral neuropathy look like in a child?
Which specialists should coordinate my child’s care?
Does the specific ITPR3 variant follow a dominant or recessive inheritance pattern?
Get notified when new evidence is published on immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.
Blanco E, Camps C, Bahal S, et al.
The Journal of experimental medicine 2025; (222(1)) doi:10.1084/jem.20220979.
PMID: 39560673 - 2
Disrupted Ca2+ homeostasis and immunodeficiency in patients with functional IP3 receptor subtype 3 defects.
Neumann J, Van Nieuwenhove E, Terry LE, et al.
Cellular & molecular immunology 2023; (20(1)):11-25 doi:10.1038/s41423-022-00928-4.
PMID: 36302985 - 3
A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease.
Molitor A, Lederle A, Radosavljevic M, et al.
Science advances 2024; (10(37)):eado5545 doi:10.1126/sciadv.ado5545.
PMID: 39270020 - 4
Two cases of combined immunodeficiency with ITPR3 mutations presenting with life-threatening severe EBV-associated hemophagocytic lymphohistiocytosis.
Yu L, Li Y, Zhang L, et al.
Frontiers in immunology 2025; (16()):1653662 doi:10.3389/fimmu.2025.1653662.
PMID: 41019080 - 5
Dominant mutations in ITPR3 cause Charcot-Marie-Tooth disease.
Rönkkö J, Molchanova S, Revah-Politi A, et al.
Annals of clinical and translational neurology 2020; (7(10)):1962-1972 doi:10.1002/acn3.51190.
PMID: 32949214 - 6
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.
Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD
Frontiers in pediatrics 2019; (7()):295 doi:10.3389/fped.2019.00295.
PMID: 31440487 - 7
Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network.
Quinn J, Modell V, Orange JS, Modell F
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):19 doi:10.1186/s13223-022-00662-6.
PMID: 35246253 - 8
Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patients.
Kindle G, Alligon M, Albert MH, et al.
medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.02.20.25322586.
PMID: 40568655
This caregiver guide is for informational purposes only and does not constitute medical advice. Your child’s immunologist and multidisciplinary team should interpret T-cell counts, EBV results, genetic findings, and transplant options for your child’s situation.